Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
Negotiating the radiologically isolated syndrome.
Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis-a computational approach.
Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort.
Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
Identifying and addressing unmet therapeutic needs in MS.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Antibody index test may aid PML diagnosis on natalizumab
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
Aging-associated changes in motor axon voltage-gated Na(+) channel function in mice.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Pages
« first
‹ previous
…
327
328
329
330
331
332
333
334
335
…
next ›
last »